Dermapharm Holding SE (XTER:DMP) Accumulated Depreciation : €0 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Dermapharm Holding SE Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Dermapharm Holding SE's quarterly accumulated depreciation increased from Sep. 2024 (€0 Mil) to Dec. 2024 (€-186 Mil) but then stayed the same from Dec. 2024 (€-186 Mil) to Mar. 2025 (€0 Mil).

Dermapharm Holding SE's annual accumulated depreciation increased from Dec. 2022 (€-125 Mil) to Dec. 2023 (€-157 Mil) and increased from Dec. 2023 (€-157 Mil) to Dec. 2024 (€-186 Mil).

Dermapharm Holding SE Accumulated Depreciation Historical Data

The historical data trend for Dermapharm Holding SE's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE Accumulated Depreciation Chart

Dermapharm Holding SE Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-85.45

-104.89

-124.53

-156.57

-185.77

Dermapharm Holding SE Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-185.77	-

Dermapharm Holding SE Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Dermapharm Holding SE Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Dermapharm Holding SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (XTER:DMP) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

DMPHF:USA 0A5J:UK DMPd:UK

Address

Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031

Website

https://www.dermapharm.com

Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.

Executives

Wilhelm Beier	Supervisory Board
Dr. Hans-georg Feldmeier	Board of Directors
Christof Dreibholz	Board of Directors
Lothar Lanz	Supervisory Board
Anja Schorn	Board Member Themis Beteiligungs-AG
Hilde Neumeyer	Board of Directors

Dermapharm Holding SE Headlines

No Headlines